Bank of America sharply raised the target price of Novavax Pharmaceuticals to $12

Gelonghui FinanceMay 11 11:11

Novavax Analyst Ratings

BenzingaMay 11 01:32

B of A Securities Upgrades Novavax to Neutral, Raises Price Target to $12

BenzingaMay 11 01:33

Buy Rating for Novavax Amid Strategic Sanofi Partnership and Solid Financial Prospects

TipRanksMay 10 23:05

Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Xenon (XENE) and BioLife Solutions (BLFS)

TipRanksMay 10 20:50

Deutsche Bank Raises Moderna's Price Target to $85 From $70

MT NewswiresMay 10 01:33

China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target

MT NewswiresMay 8 23:06

Deutsche Numis Reaffirms Their Hold Rating on BioNTech SE (BNTX)

TipRanksMay 8 22:25

HC Wainwright & Co. Maintains Buy on BioNTech, Raises Price Target to $113

BenzingaMay 8 19:20

HC Wainwright & Co. : The BioNTech (BNTX.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $107.00 to $113.00.

Zhitong FinanceMay 8 19:25

Buy Rating Affirmed for Equillium on Strong Itolizumab Data and Promising EQ101 Phase 2 Prospects

TipRanksMay 8 18:30

Buy Rating Affirmed for BioNTech Amid Strong Financials and Promising Oncology Pipeline

TipRanksMay 8 12:00

Analysts' Top Healthcare Picks: Vir Biotechnology (VIR), Rocket Pharmaceuticals (RCKT)

TipRanksMay 8 12:00

TD Cowen Adjusts BioNTech Price Target to $98 From $95, Maintains Hold Rating

MT NewswiresMay 8 00:53

Moderna Analyst Ratings

BenzingaMay 7 23:53

UBS Maintains Buy on Moderna, Raises Price Target to $151

BenzingaMay 7 23:54

Bank of Montreal, Canada: Maintaining the BioNTech (BNTX.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $123.00 to $122.00.

Zhitong FinanceMay 7 23:40

BioNTech Analyst Ratings

BenzingaMay 7 23:34

UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating

MT NewswiresMay 7 22:36

Nanoviricides Analyst Ratings

BenzingaMay 7 21:50